NO20004186D0 - Erythropoietin-liposomal dispersjon - Google Patents

Erythropoietin-liposomal dispersjon

Info

Publication number
NO20004186D0
NO20004186D0 NO20004186A NO20004186A NO20004186D0 NO 20004186 D0 NO20004186 D0 NO 20004186D0 NO 20004186 A NO20004186 A NO 20004186A NO 20004186 A NO20004186 A NO 20004186A NO 20004186 D0 NO20004186 D0 NO 20004186D0
Authority
NO
Norway
Prior art keywords
erythropoietin
cholesterol
cholesterols
lecithin
liposome based
Prior art date
Application number
NO20004186A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004186L (no
Inventor
Rainer Naff
Sandro Delmenico
Andre Wetter
Frank-Ulrich Floether
Original Assignee
Cilag Ag Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag Ag Int filed Critical Cilag Ag Int
Publication of NO20004186L publication Critical patent/NO20004186L/no
Publication of NO20004186D0 publication Critical patent/NO20004186D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
NO20004186A 1998-02-23 2000-08-22 Erythropoietin-liposomal dispersjon NO20004186D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98103111A EP0937456B1 (en) 1998-02-23 1998-02-23 Erythropoietin liposomal dispersion
PCT/IB1999/000249 WO1999042085A1 (en) 1998-02-23 1999-02-12 Erythropoietin liposomal dispersion

Publications (2)

Publication Number Publication Date
NO20004186L NO20004186L (no) 2000-08-22
NO20004186D0 true NO20004186D0 (no) 2000-08-22

Family

ID=8231466

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004186A NO20004186D0 (no) 1998-02-23 2000-08-22 Erythropoietin-liposomal dispersjon

Country Status (23)

Country Link
US (2) US6645522B2 (ru)
EP (1) EP0937456B1 (ru)
JP (1) JP4613294B2 (ru)
KR (1) KR100591871B1 (ru)
CN (1) CN1184958C (ru)
AT (1) ATE271376T1 (ru)
AU (1) AU750481B2 (ru)
BR (1) BR9908202A (ru)
CA (1) CA2320072C (ru)
CZ (1) CZ296415B6 (ru)
DE (1) DE69825137T2 (ru)
DK (1) DK0937456T3 (ru)
ES (1) ES2224299T3 (ru)
HU (1) HUP0101026A2 (ru)
IL (2) IL137808A0 (ru)
NO (1) NO20004186D0 (ru)
NZ (1) NZ506429A (ru)
PL (1) PL194502B1 (ru)
PT (1) PT937456E (ru)
RU (1) RU2218914C2 (ru)
SI (1) SI0937456T1 (ru)
SK (1) SK284036B6 (ru)
WO (1) WO1999042085A1 (ru)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE271376T1 (de) * 1998-02-23 2004-08-15 Cilag Ag Int Liposomale erythropoietin-dispersion
US7345019B1 (en) * 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
EP1111050B1 (de) * 1999-12-22 2007-03-14 Dade Behring Marburg GmbH Lösungen von humanem Procalcitonin
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
DE10219545A1 (de) * 2002-04-26 2003-11-06 Lang Florian Regulation der Apoptose
ES2343518T3 (es) * 2002-09-09 2010-08-03 Hanall Biopharma Co., Ltd. Polipeptidos interferon alfa modificados resistentes a proteasas.
JP2004115397A (ja) * 2002-09-25 2004-04-15 Fuji Photo Film Co Ltd 血管疾患治療薬を含むリポソーム
US9682054B2 (en) * 2003-02-07 2017-06-20 Prometic Pharma Smt Limited Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
AU2004257509B2 (en) * 2003-07-17 2008-12-18 Otsuka Pharmaceutical Co., Ltd. Glycoside-containing liposome
US7645733B2 (en) * 2003-09-29 2010-01-12 The Kenneth S. Warren Institute, Inc. Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
EP1537876A1 (en) * 2003-12-01 2005-06-08 BioGeneriX AG Erythropoietin solution formulation
US20080113015A1 (en) * 2004-05-24 2008-05-15 Polymun Scientific Immunbiologische Forschung Gmbh Superloaded Liposomes for Drug Delivery
KR100684380B1 (ko) 2005-05-24 2007-02-20 한국화학연구원 빗살형 폴리에틸렌글리콜을 결합한 리포솜 및 이의 제조방법
US9119782B2 (en) 2006-03-20 2015-09-01 Mary P. McCourt Drug delivery means
WO2008065372A2 (en) 2006-11-28 2008-06-05 Nautilus Biotech, S.A. Modified erythropoietin polypeptides and uses thereof for treatment
US20100310636A1 (en) * 2007-05-09 2010-12-09 Gita Sharma Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
JP6189749B2 (ja) * 2010-06-23 2017-08-30 ブライトサイド イノベーションズ，インコーポレイティド レシチン担体小胞とその作製方法
EA018472B1 (ru) * 2010-09-15 2013-08-30 Открытое Акционерное Общество "Протек" Частицы, содержащие эритропоэтин, для лечения и профилактики неврологических и гематологических заболеваний и нарушений
CN105164143B (zh) 2013-03-14 2019-02-19 杰罗米.J.申塔格 用于将分子引入到乳糜微粒中的胆固醇体囊泡
CN108066288A (zh) * 2014-01-03 2018-05-25 广州市鼍龙生物技术开发有限公司 一种鳄鱼油纳米脂质体及其制备方法
WO2015166988A1 (ja) * 2014-04-30 2015-11-05 富士フイルム株式会社 リポソームの製造方法
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
JPH087219B2 (ja) 1992-04-27 1996-01-29 雪印乳業株式会社 リポソーム封入生理活性蛋白質の定量方法
JPH06228012A (ja) 1993-01-29 1994-08-16 Dai Ichi Seiyaku Co Ltd リポソーム製剤
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US5874075A (en) * 1993-10-06 1999-02-23 Amgen Inc. Stable protein: phospholipid compositions and methods
US6214388B1 (en) * 1994-11-09 2001-04-10 The Regents Of The University Of California Immunoliposomes that optimize internalization into target cells
JP3850468B2 (ja) * 1994-12-28 2006-11-29 中外製薬株式会社 エリスロポエチンのリポソーム製剤
US5858397A (en) * 1995-10-11 1999-01-12 University Of British Columbia Liposomal formulations of mitoxantrone
ATE271376T1 (de) * 1998-02-23 2004-08-15 Cilag Ag Int Liposomale erythropoietin-dispersion

Also Published As

Publication number Publication date
KR100591871B1 (ko) 2006-06-23
PL342514A1 (en) 2001-06-18
CN1298296A (zh) 2001-06-06
WO1999042085A1 (en) 1999-08-26
EP0937456A1 (en) 1999-08-25
NO20004186L (no) 2000-08-22
CA2320072C (en) 2009-04-07
SK284036B6 (sk) 2004-08-03
SI0937456T1 (en) 2004-12-31
NZ506429A (en) 2003-03-28
JP2002503685A (ja) 2002-02-05
RU2218914C2 (ru) 2003-12-20
CZ20002959A3 (cs) 2001-10-17
ATE271376T1 (de) 2004-08-15
DE69825137T2 (de) 2005-07-21
ES2224299T3 (es) 2005-03-01
HUP0101026A2 (hu) 2001-08-28
US20040052838A1 (en) 2004-03-18
IL137808A0 (en) 2001-10-31
IL137808A (en) 2007-07-24
PT937456E (pt) 2004-10-29
PL194502B1 (pl) 2007-06-29
CZ296415B6 (cs) 2006-03-15
SK12222000A3 (sk) 2001-11-06
JP4613294B2 (ja) 2011-01-12
DK0937456T3 (da) 2004-11-08
BR9908202A (pt) 2000-10-24
CN1184958C (zh) 2005-01-19
CA2320072A1 (en) 1999-08-26
DE69825137D1 (de) 2004-08-26
AU750481B2 (en) 2002-07-18
EP0937456B1 (en) 2004-07-21
AU2180899A (en) 1999-09-06
US20020028236A1 (en) 2002-03-07
US6645522B2 (en) 2003-11-11
KR20010041152A (ko) 2001-05-15

Similar Documents

Publication Publication Date Title
NO20004186L (no) Erythropoietin-liposomal dispersjon
MY111841A (en) Injectable liposomal pharmaceutical preparations
EP0167062B1 (en) Topical composition
ATE308327T1 (de) Verwendung von 2-hydroxy-5-phenylazobenzoesäure- derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
EE9700146A (et) Hüdroksüülamiini derivaadid, mis on kasutatavad molekulaarse seostusvalgu moodustumise suurendamiseks, ja nende valmistamine
CA2259179A1 (en) Emulsion formulations for hydrophilic active agents
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
ATE301640T1 (de) Anellierte 4-carboxyamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp-hemmer
ES8700933A1 (es) Un metodo para preparar esterol-liposomas
BR9911013A (pt) Derivados de pirazol como inibidores da p-38 map quinase
CY1105318T1 (el) Φαρμακευτικες συνθεσεις για απο του στοματος και τοπικη χορηγηση
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
BR0009765B1 (pt) Compostos de ésteres de l-carnitina ou alcanoil l-carnitinase, uso dos mesmos, lipossomas contendo os referidos compostos e composições farmacêuticas e cosméticas contendo os ditos lipossomas.
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
ATE287289T1 (de) Rückfettende ester auf basis von capryl-alkohol und isostearinsäure
HUP0004058A2 (hu) Készítmények és eljárások biológiai membránok permeabilitásának reverzibilis növelésére
KR960037677A (ko) 4-인돌릴피페라지닐 유도체
SE9604193L (sv) Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav
DE60035613D1 (de) Topische kosmetische und pharmazeutische Mittel enthaltend spezifische alkoxilierte Diester der Fumarsäure
ES2180065T3 (es) Formulaciones de uso topico que contienen acetato de vitamina e.
DE69809435T2 (de) Inhibitor- und konservierungsmittelzusammensetzung
WO2001041706A3 (en) Lipid nanotubules for topical delivery
ATE206048T1 (de) Zur topischen applikation bestimmte diclofenac- lösung
DE69918974D1 (de) Perfluorierte ester von alkanoyl l-carnitin zur herstellung von kationischen lipiden zur intrazellulären verabreichung pharmakologisch aktiver verbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application